ISDS Case Map
health
Republicans' Project 2025 manifesto suggests opening up NHS to 'foreign competition'.
India and South East Asian nation Cambodia deliberated upon diversification of the trade basket by identifying new products, bilateral investment treaty, recognition of Indian pharmacopoeia and collaboration in the pharma sector.
It is no coincidence that just five days before the amendments were announced, India signed a Free Trade Agreement with the European Free Trade Association.
MSF is concerned that certain clauses related to intellectual property in this trade deal could significantly undermine the use of existing public health measures enshrined in Indian patent law.
Thirty years after NAFTA came into effect in 1994, the economic data suggests a somber conclusion: The three countries’ working classes are worse off today than they were before
Intellectual property protection for the Swiss pharmaceutical industry has been a key sticking point in negotiations on a free trade agreement with India. Now there seems to be a breakthrough in talks after 16 years. What’s changed?
The clause in the draft free trade agreement text could delay access to affordable, generic versions of patented drugs in India by a minimum of six years, according to documents.
The “TRIPS-Plus” provisions in the India-UK Agreement are a dangerous attempt to increase the power of pharmaceutical companies by placing profits before public health.
MSF and over 50 UK-based civil society organisations and individuals sent this open letter to United Kingdom Prime Minister, urging him to commit that the UK-India Free Trade Agreement will not gut the public health safeguards that are in India’s intellectual property laws.
